Evaluation of unilateral corneal collagen cross-linking on fellow untreated eyes of patients with keratoconus

buir.contributor.authorKars, Meltem Ece
buir.contributor.orcidKars, Meltem Ece|0000-0001-5922-5608
dc.citation.epage8
dc.citation.issueNumber3
dc.citation.spage1
dc.citation.volumeNumber87
dc.contributor.authorAkçay, Emine
dc.contributor.authorEnsari Delioglu, Ezgi Naz
dc.contributor.authorKars, Meltem Ece
dc.contributor.authorDemir, Pervin
dc.contributor.authorÇağıl, Nurullah
dc.date.accessioned2025-02-17T11:13:00Z
dc.date.available2025-02-17T11:13:00Z
dc.date.issued2023-10-20
dc.departmentDepartment of Molecular Biology and Genetics
dc.description.abstract###### **Purpose:** This study aimed to examine the effects of unilateral corneal collagen cross-linking treatment on visual acuity and the topographic findings of the fellow untreated eye of patients who had bilateral progressive keratoconus. ###### **Methods:** Patients with progressive keratoconus who underwent cross-linking treatment were screened retrospectively. A total of 188 untreated eyes of 188 patients whose eyes were treated unilaterally with either standard or accelerated cross-linking and refused cross-linking procedure for the fellow eye were included. Visual acuity and topographic findings of the fellow untreated eyes were obtained preoperatively and postoperatively at the 1<sup>st</sup>, 3<sup>rd</sup>, 6<sup>th</sup>, 12<sup>th</sup>, 24<sup>th</sup>, 30<sup>th</sup>, and 36<sup>th</sup> months. ###### **Results:** The change over time of variables examined was similar in the untreated eyes of patients who received standard and accelerated cross-linking methods (p>0.05). At the 12th month, 136 (95.8%) untreated eyes were stable according to progression criteria. Only 4 (8%) eyes were progressive at the 24th month. No progression was observed in any of the 16 patients with a 36-month follow up. ###### **Conclusions:** The results showed that the fellow untreated eyes of patients with bilateral progressive keratoconus did not have significant progression rates after unilateral cross-linking treatment.
dc.identifier.doi10.5935/0004-2749.2022-0004
dc.identifier.eissn1678-2925
dc.identifier.issn0004-2749
dc.identifier.urihttps://hdl.handle.net/11693/116313
dc.language.isoEnglish
dc.publisherConselho Brasileiro de Oftalmologia
dc.relation.isversionofhttp://dx.doi.org/10.5935/0004-2749.2022-0004
dc.rightsCC BY 4.0 (Attribution 4.0 International Deed)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.source.titleArquivos Brasileiros De Oftalmologia
dc.subjectCorneal topography
dc.subjectCross-linking reagents
dc.subjectKeratoconus
dc.subjectPhotosensitizing agents
dc.subjectCollagen/therapeutic use
dc.subjectPhotochemotherapy
dc.subjectVisual acuity
dc.titleEvaluation of unilateral corneal collagen cross-linking on fellow untreated eyes of patients with keratoconus
dc.title.alternativeA avaliação da reticulação unilateral do colágeno corneano em olhos não tratados de pacientes com ceratocone
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Evaluation_of_unilateral_corneal_collagen_cross-linking_on_fellow_untreated_eyes_of_patients_with_keratoconus.pdf
Size:
437.54 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: